Bridging the distance: a prospective tele-oncology study in Northern Norway
Bridging the distance: a prospective tele-oncology study in Northern Norway
复制标题
DOI：
10.1007/s00520-011-1319-1
复制
发表时间：
2012-09-01
影响因子：
3.1
通讯作者：
Nordoy, Tone
中科院分区：
文献类型：
--
作者：
Donnem, Tom;Ervik, Bente;Nordoy, Tone
北挪威大学医院（UNN）是一家三级医院，主要负责在挪威北部偏远地区提供专门的癌症保健。建立了每周视频会议，使当地医院的临床医生和五个不同社区的初级癌症保健提供者能够与联合国网络的癌症专科保健服务部门讨论病例。在本研究中，我们旨在评估这些风险投资的可行性。这是一项前瞻性注册研究。在UNN收集了描述性数据，对于在VC讨论的每个患者，由负责患者的当地卫生保健提供者完成了一项调查。在18个月的时间里，167例病例（101例患者）被讨论。每次风险投资中位数为7名卫生保健提供者。据当地的医生和护士说，在96%的病例中，风险投资对充分的病人护理给予了“相当多”或“非常多”的信心。他们报告说，由于风险投资，85%的患者护理将得到“相当多”或“非常多”的改善。等待VC的平均天数为2.0天（范围，0-7；SD, 2.0），显著短于使用替代咨询的估计等待时间（平均，10.2天（范围，0-30；SD, 5.8）） （P < 0.001）。VC可能是一种有用的补充工具，用于支持地方医院和偏远社区的初级卫生保健提供者努力提供高效和高质量的癌症治疗。
The University Hospital of North Norway (UNN) is a tertiary-level hospital and has the main responsibility of providing specialized cancer health care in the remote area of Northern Norway. Weekly videoconferences (VCs) have been established to enable clinicians at a local hospital and primary cancer health care providers in five different communities to discuss cases with specialist cancer care services at UNN. In this study, we aimed to evaluate the feasibility of these VCs.This is a prospective registration study. Descriptive data were collected at UNN, and for each patient discussed at the VC, a survey was completed by the local health care provider responsible for the patient.During an 18-month period, 167 cases were discussed (101 patients). A median of 7 health care providers participated in each VC. According to the local physicians and nurses, the VCs contributed in 96% of cases to give "quite a bit" or "very much" confidence in adequate patient care. They reported that patient care in 85% of cases would be improved "quite a bit" or "very much" due to the VC. The mean number of days waiting for VC were 2.0 days (range, 0-7; SD, 2.0) and was significantly shorter (P < 0.001) than the estimated time waiting if alternative consultations were to be used (mean, 10.2 days (range, 0-30; SD, 5.8)).VC may be a useful supplemental tool to support primary health care providers at local hospitals and remote communities in their effort to offer efficient and high-quality cancer care.